---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-127595"
form_type: "8-K"
ticker: "ANTX"
cik: "0001880438"
company_name: "AN2 Therapeutics, Inc."
filed_at: "2025-05-27T23:59:59+00:00"
generated_at: "2026-05-20T11:29:21.367811+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# AN2 Therapeutics stockholders elect three Class III directors and ratify PwC as auditor

## Summary
- Eric Easom, Stephanie Wong, and Joseph Zakrzewski elected as Class III directors for term expiring 2028.
- Easom received 13,983,213 votes for; Wong 10,584,641; Zakrzewski 10,928,200; each had 3,403,334 broker non-votes.
- Ratification of PricewaterhouseCoopers LLP as independent auditor passed with 23,736,942 votes for, 47,413 against, 144,085 abstentions.
- Approximately 79.50% of outstanding shares (23,928,440) represented at the meeting, constituting a quorum.

## SEC filing metadata
- accession: 0001193125-25-127595
- form_type: 8-K
- ticker: ANTX
- cik: 0001880438
- company_name: AN2 Therapeutics, Inc.
- filed_at: 2025-05-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1880438/000119312525127595/0001193125-25-127595-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1880438/000119312525127595/d82533d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-127595
- JSON: https://secwatch.observer/filing/0001193125-25-127595.json
- Plain text: https://secwatch.observer/filing/0001193125-25-127595.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.